Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB

被引:11
作者
Stopforth, Richard J. [1 ]
Cleary, Kirstie L. S. [1 ]
Cragg, Mark S. [1 ]
机构
[1] Univ Southampton, Antibody & Vaccine Grp, Canc Sci Unit, Southampton Gen Hosp,Fac Med, Southampton SO16 6YD, Hants, England
基金
英国生物技术与生命科学研究理事会;
关键词
Monoclonal antibody; immunotherapy; antigenic modulation; Fc gamma RIIB; CD32B; immunomodulation; B-CELL RECEPTOR; ANTITUMOR-ACTIVITY; ENGAGEMENT DRIVES; IN-VIVO; ACTIVATION; CD32B; IIB; POLYMORPHISM; EXPRESSION; MECHANISM;
D O I
10.1007/s10875-016-0247-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Monoclonal antibodies (mAb) are revolutionising the treatment of many different diseases. Given their differing mode of action compared to most conventional chemotherapeutics and small molecule inhibitors, they possess the potential to be independent of common modes of treatment resistance and can typically be combined readily with existing treatments without dose-limiting toxicity. However, treatments with mAb rarely result in cure and so a full understanding of how these reagents work and can be optimised is key for their subsequent improvement. Here we review how an understanding of the biology of the inhibitory Fc receptor, Fc gamma RIIB (CD32B), is leading to the development of improved mAb treatments.
引用
收藏
页码:S88 / S94
页数:7
相关论文
共 47 条
[1]   Cell Contact-Dependent Priming and Fc Interaction with CD32+ Immune Cells Contribute to the TGN1412-Triggered Cytokine Response [J].
Bartholomaeus, Patrick ;
Semmler, Linda Y. ;
Bukur, Thomas ;
Boisguerin, Valesca ;
Roemer, Paula S. ;
Tabares, Paula ;
Chuvpilo, Sergey ;
Tyrsin, Dmitry Y. ;
Matskevich, Alexey ;
Hengel, Hartmut ;
Castle, John ;
Unig, Thomas H. ;
Kalinke, Ulrich .
JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2091-2098
[2]   Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection [J].
Beers, Stephen A. ;
French, Ruth R. ;
Chan, H. T. Claude ;
Lim, Sean H. ;
Jarrett, Timothy C. ;
Vidal, Regina Mora ;
Wijayaweera, Sahan S. ;
Dixon, Sandra V. ;
Kim, Hyungjin ;
Cox, Kerry L. ;
Kerr, Jonathan P. ;
Johnston, David A. ;
Johnson, Peter W. M. ;
Verbeek, J. Sjef ;
Glennie, Martin J. ;
Cragg, Mark S. .
BLOOD, 2010, 115 (25) :5191-5201
[3]   SHIP modulates immune receptor responses by regulating membrane association of Btk [J].
Bolland, S ;
Pearse, RN ;
Kurosaki, T ;
Ravetch, JV .
IMMUNITY, 1998, 8 (04) :509-516
[4]   STRUCTURE AND EXPRESSION OF HUMAN-IGG FCRII(CD32) - FUNCTIONAL-HETEROGENEITY IS ENCODED BY THE ALTERNATIVELY SPLICED PRODUCTS OF MULTIPLE GENES [J].
BROOKS, DG ;
QIU, WQ ;
LUSTER, AD ;
RAVETCH, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1369-1385
[5]   Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses [J].
Bruhns, Pierre ;
Iannascoli, Bruno ;
England, Patrick ;
Mancardi, David A. ;
Fernandez, Nadine ;
Jorieux, Sylvie ;
Daeron, Marc .
BLOOD, 2009, 113 (16) :3716-3725
[6]  
BUDDE P, 1994, J BIOL CHEM, V269, P30636
[7]   Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies [J].
Chu, Seung Y. ;
Vostiar, Igor ;
Karki, Sher ;
Moore, Gregory L. ;
Lazar, Greg A. ;
Pong, Erik ;
Joyce, Patrick F. ;
Szymkowski, David E. ;
Desjarlais, John R. .
MOLECULAR IMMUNOLOGY, 2008, 45 (15) :3926-3933
[8]   Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors [J].
Clynes, R ;
Maizes, JS ;
Guinamard, R ;
Ono, M ;
Takai, T ;
Ravetch, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :179-185
[9]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[10]   Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity [J].
Cohen-Solal, Joel F. G. ;
Cassard, Lydie ;
Fournier, Emilie M. ;
Loncar, Shannon M. ;
Fridman, Wolf Herman ;
Sautes-Fridman, Catherine .
DERMATOLOGY RESEARCH AND PRACTICE, 2010, 2010